Recent Posts by admin

Firalis obtains an EU funding likely the largest ever received by a French Biotech!

Firalis-initiated public-private consortium project, SAFE-T,has been approved for a major European funding. The SAFE-T Project aims to qualify Translational Safety Biomarkers in clinics. It is the highest budget financed among the 18 first calls launched in 2008 by the Innovative Medicines Initiative-Joint Undertaking (IMI-JU). Firalis created the SAFE-T (Safer And Faster Evidence-based Translation) Applicant Consortium…
Read more

Firalis Analyses Complex x-omics data

Firalis servicing team analyses Complex x-omics data, and interprets them with regard to basic science and to the clinical relevance. Firalis is also pleased to contribute to the publication of such x-omics data. Improved xenogenic hepatocyte implantation into nude mouse liver parenchyma with acute liver failure when followed by repeated anti-Fas antibody (Jo2) treatment. Isabelle…
Read more

Firalis Obtains OSEO Innovation Support !

Firalis has created and coordinates a European applicant consortium that will develop a generic qualification process for candidate translational safety biomarkers in the frame of IMI Joint Undertaking.
Read more

Recent Comments by admin

No comments by admin yet.